Search results
Heather Bresch (née Manchin; born June 27, 1969) is an American business executive. In 2012, she was named as the chief executive officer (CEO) of Netherlands-based pharmaceutical company Mylan, becoming the first woman to run a Fortune 500 pharmaceutical company. Bresch retired in 2020, upon the closing of Mylan’s combination ...
29 de jul. de 2019 · Bresch has led Mylan since 2012, overseeing its growth from a generics company to a global pharmaceutical giant. She will step down in mid-2020, after the deal with Pfizer's Upjohn business, following years of controversies and investigations.
Heather Bresch is the chief executive officer and a board member of Mylan, a global generics and specialty pharmaceutical company. She has advocated for access to medicine, especially for HIV/AIDS, biologics and food allergies, and has led several acquisitions and policy changes at Mylan.
17 de mar. de 2022 · Heather Bresch, the former CEO of Mylan and daughter of Sen. Joe Manchin, faces antitrust lawsuits over the price hikes of EpiPens. The article exposes how Bresch shut down a union plant in West Virginia and fabricated her MBA degree.
7 de sept. de 2021 · Heather Bresch, the former CEO of Mylan and the daughter of Sen. Joe Manchin, colluded with Pfizer to eliminate its EpiPen competitor and raise prices. She also approved a scheme to force customers to buy two EpiPens at once, regardless of medical need.
Learn about Heather Bresch, the CEO of Mylan, a generic drug company that faced challenges and opportunities in the pharmaceutical industry. See her achievements, education, personal stats and Forbes lists ranking.
View Heather Manchin’s profile on LinkedIn, a professional community of 1 billion members. I recently transitioned from CEO of Mylan to being a Champion of Change for healthcare…
